1.1.
Køber
Officielt navn: NHS National Services Scotland (NSS)
Køberens retlige status: Offentligretligt organ
Den ordregivende myndigheds aktivitet: Sundhed
« Tilbage til oversigten over alle licitationer
850409-2025 - Planlægning
850409-2025 - Planlægning
Det Forenede Kongerige, Spanien, Danmark, Polen, Grækenland – Forskning og eksperimentel udvikling – PreCommercial Procurement (PCP) to buy R&D (research and development) services on innovative and sustainable solutions to transition healthcare supply chains from linear to circular models – REHEAL.
OJ S 246/2025 22/12/2025
Forhåndsmeddelelse eller vejledende periodisk bekendtgørelse, der kun er anvendt til informationsformål
Tjenesteydelser
1. Køber
1.1.
Køber
Officielt navn: Servizo Gallego de Salud – Area Sanitaria de Lugo, A Marina y Monforte de Lemos
Køberens retlige status: Offentligretligt organ
Den ordregivende myndigheds aktivitet: Sundhed
1.1.
Køber
Officielt navn: Region Hovedstaden (REGIONH)
Køberens retlige status: Offentligretligt organ
Den ordregivende myndigheds aktivitet: Sundhed
1.1.
Køber
Officielt navn: Fundacja Klaster Lifescience Krakow (KLSK)
Køberens retlige status: Offentligretligt organ
Den ordregivende myndigheds aktivitet: Sundhed
1.1.
Køber
Officielt navn: Mitera Idiotiki Geniki, Maieytiki, Gynaikologiki Kai Paidiatriki Kliniki Anonymi Etaireia (MITERA)
Køberens retlige status: Offentligretligt organ
Den ordregivende myndigheds aktivitet: Sundhed
2. Procedure
2.1.
Procedure
Titel: PreCommercial Procurement (PCP) to buy R&D (research and development) services on innovative and sustainable solutions to transition healthcare supply chains from linear to circular models – REHEAL.
Beskrivelse: This PIN provides early information about the expected starting date and purchase volume and about the open market consultation that is organised in preparation of this precommercial procurement (PCP). The procurement aims to trigger new solutions to be developed and tested to address the following challenge: REHEAL aims to stimulate the development of new solutions that will support the transition of healthcare supply chains from linear to circular models to enhance sustainability and resilience. Key areas include developing supply chain management platforms that prioritise product longevity, material tracking, and regulatory compliance, employing advanced data analytics and AI to optimise reverse logistics and explore recovery opportunities. Solutions should enable scenario analysis and modelling, allowing healthcare providers to identify and implement the most impactful strategies tailored to regional needs.
2.1.1.
Formål
Kontraktens hovedformål: Tjenesteydelser
Primær klassifikation (cpv): 73100000 Forskning og eksperimentel udvikling
Supplerende klassifikation (cpv): 73110000 Forskning, 72212445 Udvikling af programmel til håndtering af kundeoplysninger og -relationer (CRM), 72222300 Tjenesteydelser i forbindelse med informationsteknologi, 90713000 Rådgivning i forbindelse med miljøspørgsmål, 90714100 Miljøoplysningssystemer, 90711300 Analyse af miljøindikatorer for andet end bygge- og anlægsarbejder, 80500000 Uddannelsestilbud, 79342200 Servicevirksomhed i forbindelse med salgsfremme, 90711000 Miljøvurdering for andet end bygge- og anlægsarbejder, 72212783 Udvikling af programmel til indholdsforvaltning, 85100000 Tjenesteydelser inden for sundhedsvæsenet
2.1.2.
Udførelsessted
By: Edinburgh
Postnummer: EH12 9EB
Land: Det Forenede Kongerige
Yderligere oplysninger: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
2.1.2.
Udførelsessted
By: Lugo
Landsdel (NUTS): Lugo (ES112)
Land: Spanien
Yderligere oplysninger: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
2.1.2.
Udførelsessted
By: Copenhagen
Landsdel (NUTS): Københavns omegn (DK012)
Land: Danmark
Yderligere oplysninger: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
2.1.2.
Udførelsessted
By: Kraków
Landsdel (NUTS): Miasto Kraków (PL213)
Land: Polen
Yderligere oplysninger: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
2.1.2.
Udførelsessted
By: Attiki
Landsdel (NUTS): Δυτική Αττική (EL306)
Land: Grækenland
Yderligere oplysninger: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
2.1.3.
Værdi
Anslået værdi eksklusiv moms: 3 000 000,00 EUR
2.1.4.
Generelle oplysninger
Yderligere oplysninger: The research and development (R&D) services will be carried out primarily within the European Union and/or in countries associated with the Horizon Europe Programme. At least 50% of the total value of the R&D activities shall take place within the EU or associated countries. Contractors must ensure that none of the contracted services are performed in countries nor by entities that are subject to EU restrictive measures under Article 29 of the Treaty on the European Union (TEU) and Article 215 of the Treaty on the Functioning of the EU (TFEU)23 (sanctions). They must also ensure that none of the goods procured or used for the procurement were developed, produced or supplied in countries or by entities that are subject to such restrictive measures. This procurement is exempted from the WTO Government Procurement Agreement (GPA), the EU public procurement directives and the national laws that implement them. This is because it concerns the procurement of R&D services where the benefits do not accrue exclusively to the contracting authority for its use in the conduct of its own affairs. Publication of this contract notice in the EU Official Journal is not to be understood as a waiver of this exemption. Publication is made on a voluntary basis and the procurement will not follow the procedures under the EU public procurement directives, but rather the procedure described in the tender documentation. This PIN is published to announce an open market consultation on a future procurement procedure. The PIN is not a commitment to procure. This procurement is funded by the European Union's Horizon Europe Research and Innovation Programme under Grant Agreement No. 101226919 – ReHEAL https://www.rehealhorizon.eu . *The EU has awarded a grant for this procurement but is not participating as a contracting authority in the procurement.* For additional information, please contact: REHEAL Project Coordination Team, Email:pcp@rehealhorizon.eu More information is on the REHEAL website https://www.rehealhorizon.eu.
Retsgrundlag:
Anden
3. Del
3.1.
Teknisk ID for delen: PAR-0001
Titel: PreCommercial Procurement (PCP) to buy R&D (research and development) services on innovative and sustainable solutions to transition healthcare supply chains from linear to circular models – REHEAL.
Beskrivelse: This PCP procurement is a joint procurement by different procurers across Europe that are all facing the same common challenge and are thus looking for similar solutions (socalled ‘Buyers Group’).The procurement will take the form of a precommercial procurement (PCP) under which R&D service contracts will be awarded to a number of R&D providers in parallel in a phased approach. This will make it possible to compare competing alternative solutions. Each selected R&D provider will be awarded a framework agreement that covers the following R&D phases and a specific contract per phase.Procurement will take the form of a precommercial procurement (PCP), that will allow procurers to buy R&D from several competing suppliers in parallel; to compare alternative solution approaches and to identify the best valueformoney solutions that the market can deliver to address those needs. The PCP will be structured as a fasttrack PCP, specifically designed to accelerate innovation cycles and reduce timetoimpact whilst remaining fully compliant with Horizon Europe PCP principles. In contrast to traditional PCPs that strictly separate prototyping and piloting into distinct phases, REHEAL adopts a fasttrack approach in which prototyping and piloting are combined into a single integrated R&D phase. This approach is justified by the digital, softwareintensive nature of the expected solutions, which enables rapid iteration, continuous testing and early validation in real operational environments. The PCP will be organised into three consecutive phases: Phase 1 – Solution design and feasibility: Selected contractors will elaborate detailed solution designs, technical architectures, and feasibility studies addressing the REHEAL challenge, including risk assessment and validation plans. Phase 2 – Prototyping and piloting (combined phase): Contractors will develop functional prototypes and pilot them directly in operational healthcare environments across the Buyers Group sites. Prototyping and piloting are grouped together to enable rapid learning loops, realworld testing, and early assessment of usability, scalability, sustainability impact, and integration into existing healthcare supply chains. Phase 3 – followup procurement: subject to the successful completion of Phase 2 and availability of funding, the REHEAL Buyers Group may launch a separate followup procurement to deploy and upscale the most promising solution(s). This Phase 3 is not part of the PCP itself, but is foreseen as a potential next step to ensure market uptake and impact, in line with Horizon Europe PCP guidance. After each PCP phase, interim evaluations will be carried out, and the contractors offering the best value for money will be invited to progress to the next phase. Each selected operator will receive a framework contract, with specific contracts awarded per phase. The selected operators will retain ownership of the intellectual property rights (IPRs) they generate during the PCP and will be able to use them to exploit the full market potential of the solutions developed. All interested operators are invited to take part in the upcoming open market consultation (OMC) (regardless of their geographic location, size or governance structure of their organisation). The OMC will be organised as a series of meetings. These meetings will provide you with an overview on the procurement objectives, the PCP process and the main clauses of the contract. You will also have the opportunity to ask questions. A first EUlevel online webinar will be held on 11 February 2026, introducing the project, challenge, requirements, Buyers Group, overall PCP process and timeline, to tools available to support applicants. This will be followed by a series of five live meetings hosted in each of the procurer locations mentioned in under Section I.1) During those meetings, the procurers will offer presentations in their own local languages, namely English, Spanish, Danish, Polish and Greek. These meetings will take place between 16 – 27 February 2026. The meetings will be followed by an EUlevel live event on 4 March and a final EU webinar, on 31 March 2026, in English. Registration for OMC meetings will be available on the REHEAL website https://www.rehealhorizon.eu – from 19 January 2026. The contract notice is expected to be published in July 2026 and the procurement is expected to start in late 2026 and end in late 2028. Testing is expected to take place in Scotland (UK), Galicia (Spain), Region Hovedstaden (Denmark), Krakow (Poland), and Athens (Greece). This testing may also serve as a first customer test reference for the contractors. The selected suppliers will retain ownership of the intellectual property rights (IPRs) they generate during the PCP and will be able to use them to exploit the full market potential of the solutions developed, i.e. beyond the procurement.
3.1.1.
Formål
Kontraktens hovedformål: Tjenesteydelser
Primær klassifikation (cpv): 73100000 Forskning og eksperimentel udvikling
3.1.2.
Udførelsessted
By: Edinburgh
Land: Det Forenede Kongerige
Yderligere oplysninger: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
3.1.2.
Udførelsessted
By: Lugo
Landsdel (NUTS): Lugo (ES112)
Land: Spanien
Yderligere oplysninger: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
3.1.2.
Udførelsessted
By: Copenhagen
Landsdel (NUTS): Københavns omegn (DK012)
Land: Danmark
Yderligere oplysninger: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
3.1.2.
Udførelsessted
By: Kraków
Landsdel (NUTS): Miasto Kraków (PL213)
Land: Polen
Yderligere oplysninger: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
3.1.2.
Udførelsessted
By: Attiki
Landsdel (NUTS): Δυτική Αττική (EL306)
Land: Grækenland
Yderligere oplysninger: Testing is expected to take place in United Kingdom (Scotland), Spain (Galicia), Denmark (Region Hovedstaden); Poland (Małopolska Region), Greece (Attiki)
3.1.3.
Varighed
Anden varighed: Ukendt
3.1.4.
Værdi
Anslået værdi eksklusiv moms: 3 000 000,00 EUR
3.1.5.
Generelle oplysninger
Udbuddet er omfattet af aftalen om offentlige udbud (GPA): nej
Dette udbud er også egnet for små og mellemstore virksomheder (SMV'er): ja
3.1.9.
Yderligere oplysninger, mægling og gennemgang
Organisation med ansvar for mægling: NHS National Services Scotland (NSS)
Organisation med ansvar for klager: NHS National Services Scotland (NSS)
Organisation, der leverer yderligere oplysninger om klageprocedurerne: NHS National Services Scotland (NSS)
8. Organisationer
8.1.
ORG-0001
Officielt navn: NHS National Services Scotland (NSS)
Registreringsnummer: GB 654 851 612
Postadresse: 1 South Gyle Crescent
By: Edinburgh
Postnummer: EH12 9EB
Land: Det Forenede Kongerige
Enhed: REHEAL Coordination Team
Telefon: +44 1312756000
Denne organisations roller:
Køber
Organisation med ansvar for klager
Organisation, der leverer yderligere oplysninger om klageprocedurerne
Organisation med ansvar for mægling
8.1.
ORG-0002
Officielt navn: Servizo Gallego de Salud – Area Sanitaria de Lugo, A Marina y Monforte de Lemos
Registreringsnummer: Q2729003A
Postadresse: Doctor Ulises Romero No. 1 – 2a planta
By: Lugo
Postnummer: 27003
Landsdel (NUTS): Lugo (ES112)
Land: Spanien
Enhed: REHEAL Coordination Team
Telefon: +34 981580633
Denne organisations roller:
Køber
8.1.
ORG-0003
Officielt navn: Region Hovedstaden (REGIONH)
Registreringsnummer: 30113721
Postadresse: Regionsgården – Kongens Vænge 2
By: Hillerød
Postnummer: 3400
Landsdel (NUTS): Københavns omegn (DK012)
Land: Danmark
Enhed: REHEAL Coordination Team
Telefon: +45 21537888
Denne organisations roller:
Køber
8.1.
ORG-0004
Officielt navn: Fundacja Klaster Lifescience Krakow (KLSK)
Registreringsnummer: 0000458418
Postadresse: Bobrzyńskiego 14
By: Kraków
Postnummer: 30-348
Landsdel (NUTS): Miasto Kraków (PL213)
Land: Polen
Enhed: REHEAL Coordination Team
Telefon: +48 789 490 146
Denne organisations roller:
Køber
8.1.
ORG-0005
Officielt navn: Mitera Idiotiki Geniki, Maieytiki, Gynaikologiki Kai Paidiatriki Kliniki Anonymi Etaireia (MITERA)
Registreringsnummer: 000288501000 (GEMI)
Postadresse: 6, Erythrou Stavrou
By: Marousi, Athens
Postnummer: 15123
Landsdel (NUTS): Δυτική Αττική (EL306)
Land: Grækenland
Enhed: REHEAL Coordination Team
Telefon: +30 2117508697
Denne organisations roller:
Køber
8.1.
ORG-0000
Officielt navn: Publications Office of the European Union
Registreringsnummer: PUBL
By: Luxembourg
Postnummer: 2417
Landsdel (NUTS): Luxembourg (LU000)
Land: Luxembourg
Telefon: +352 29291
Denne organisations roller:
TED eSender
Oplysninger om bekendtgørelsen
Bekendtgørelsens ID: 7bb3386e-bc97-41a2-a449-e938965a8d4c - 01
Formulartype: Planlægning
Bekendtgørelsestype: Forhåndsmeddelelse eller vejledende periodisk bekendtgørelse, der kun er anvendt til informationsformål
Bekendtgørelsesundertype: 4
Afsendelsesdato for bekendtgørelsen: 19/12/2025 11:00:07 (UTC+00:00) vesteuropæisk tid, GMT
Bekendtgørelsens officielle sprog: engelsk
Bekendtgørelsesnummer: 850409-2025
EUT-S-nummer: 246/2025
Offentliggørelsesdato: 22/12/2025
Den påtænkte dato for offentliggørelse af en udbudsbekendtgørelse inden for denne procedure: 16/06/2026
